F058 Itch
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Chronic pruritus, arising idiopathically or in association with cutaneous or systemic disease, may be incapacitating. This session is meant for the clinician who wants to understand how itch arises and how best to approach itch management in different clinical scenarios, including itch associated with allergic, systemic, and neuropathic disorders. Expert itch clinicians and researchers will explain our evolving understanding of itch pathophysiology and communicate their experience in diagnosing and managing challenging itches, including severe atopic dermatitis, prurigo nodularis, urticarial disorders and neuropathic disease. Novel and pipeline therapies and devices for the management of chronic itch will be discussed.
LEARNING OBJECTIVES
Categorize different types of chronic itch and utilize appropriate diagnostic tests in the evaluation of patients suffering form chronic pruritus.
Incorporate neuromodulators, immunomodulators, and alternative therapies into the management of patients with chronic itch.
Describe new or pipeline agents to treat chronic itch.
SCHEDULE
5:00 PM
Introduction
Sarina Elmariah, MD, FAAD
5:05 PM
The Dermatologist's Playbook for Chronic Itch
Shawn Kwatra, MD, FAAD
5:25 PM
What’s Best and What’s Next for systemic itch and CPUO
Gil Yosipovitch, MD
5:45 PM
Updates in the management of itch in urticarial disorders
Martin Metz, MD
6:05 PM
Updates in the Treatment Landscape of Prurigo Nodularis
Sonja Stander, MD, IFAAD
6:25 PM
Managing itch and expectations in atopic and eczematous dermatitis
Sarina Elmariah, MD, FAAD
6:45 PM
Faculty Panel Discussion & Questions
SPEAKERS
Sarina Elmariah, MD, FAAD
Shawn Kwatra, MD, FAAD
Martin Metz, MD
Sonja Stander, MD, IFAAD
Gil Yosipovitch, MD
SPEAKER DISCLOSURES
Sarina Elmariah, MD, FAAD
Eli Lilly – Other(Honoraria); Galderma Laboratories, LP – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Martin Metz, MD
AbbVie – Speaker(Honoraria); Alk-Abelló – Speaker/Faculty Education(Honoraria); Almirall – Speaker(Honoraria), Speaker/Faculty Education(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); argenx – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); AstraZeneca – Advisory Board(Honoraria); Astria Therapeutics – Advisory Board(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Celldex – Advisory Board(Honoraria); Celltrion – Speaker(Honoraria); Deep Apple Therapeutics – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Escient Pharmaceuticals, Inc – Advisory Board(Honoraria); Evommune, Inc. – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); GlaxoSmithKline Immunology – Advisory Board(Honoraria); Granular Therapeutics – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Jasper Therapeutics – Advisory Board(Honoraria); Johnson & Johnson Pharmaceutical Research & Development – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); RAPT Therapeutics – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); Santa Ana Bio – Advisory Board(Honoraria); Septerna – Advisory Board(Honoraria);
Sonja Stander, MD, IFAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Bellus Health – Consultant(Honoraria); BMS – Speaker(Honoraria); Cara Therapeutics – Consultant(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Galderma – Speaker(Honoraria); Galderma Laboratories, LP – Consultant(Honoraria); Galderma Research & Development, LLC – Consultant(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Kiniksa Pharmaceuticals, Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Novartis – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi Aventis – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Speaker(Honoraria); University Hospital Muenster – Advisory Board(No Compensation Received); Vifor Pharma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); WebMD – Consultant (1099 relationship)(Honoraria);
Gil Yosipovitch, MD
AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);